AMPLI — Amplitude Surgical SA Balance Sheet
0.000.00%
- €300.13m
- €398.21m
- €106.02m
- 33
- 27
- 87
- 44
Annual balance sheet for Amplitude Surgical SA, fiscal year end - June 30th, EUR millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 36.7 | 30.7 | 21 | 37.2 | 29.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13.5 | 16.7 | 17.8 | 19 | 20.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 93.1 | 94.4 | 96.7 | 95.5 | 94.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 45.7 | 42.2 | 33.5 | 37.3 | 41.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 275 | 269 | 259 | 266 | 279 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 46.2 | 38.4 | 43.8 | 41.3 | 46.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 203 | 210 | 205 | 170 | 183 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 72.5 | 58.9 | 54.2 | 95.8 | 95.8 |
| Total Liabilities & Shareholders' Equity | 275 | 269 | 259 | 266 | 279 |
| Total Common Shares Outstanding |